Hypoplastic left heart syndrome is a rare and serious heart condition present at birth, where the left side of the heart does not develop properly and cannot pump enough blood to the body. While this diagnosis brings challenges, advances in medical care and surgery over recent decades have transformed the outlook for these children.

Prognosis: Understanding the Journey Ahead

When a baby receives a diagnosis of hypoplastic left heart syndrome, parents naturally want to understand what the future holds. This is a deeply sensitive topic, and it’s important to approach it with both honesty and hope. The outlook for children with HLHS has changed dramatically over the past forty years. What was once considered universally fatal in the 1970s has become a condition where many children can now survive into adulthood with proper medical and surgical care.

About 1 in 3,800 to 3,955 babies in the United States are born with HLHS each year, making it quite rare but accounting for roughly 2% to 3% of all congenital heart defects^[3][2]. The condition affects more boys than girls. While HLHS remains one of the most challenging congenital heart defects to manage, survival rates have improved significantly. Studies show that approximately 70% of children who undergo the three-staged surgical approach reach adulthood^[8].

The journey is not without significant challenges. Children with HLHS typically experience some degree of neurodevelopmental and motor delay as they grow. These delays may affect how quickly they reach developmental milestones compared to other children. As adults, individuals who had HLHS as children face an increased risk of heart failure, which means their heart may struggle to pump blood effectively as they age. The surgical repairs performed in childhood are palliative, meaning they help manage the condition but are not a cure^[3].

Survival rates vary depending on many factors. Children who have additional risk factors at birth—such as being born prematurely, having very low birth weight, being in shock, or having other medical conditions—face greater challenges. However, even for these high-risk babies, survival chances have improved. Recent studies using newer surgical approaches for the most fragile infants have shown survival rates of about 70%, whereas in the past, these babies had extremely limited survival chances^[16].

Natural Progression Without Treatment

Understanding what happens if HLHS goes untreated helps explain why immediate medical intervention is so critical. When a baby has HLHS, the left side of their heart—which normally pumps oxygen-rich blood to the entire body—is severely underdeveloped. The left ventricle (the heart’s main pumping chamber), the mitral and aortic valves, and the ascending portion of the aorta are all too small or not formed properly^[4].

Before birth, babies with HLHS survive because of special connections that exist in all developing babies. One of these connections is called the ductus arteriosus, a blood vessel that allows blood to bypass the underdeveloped left side of the heart. Another opening, called the foramen ovale, sits between the two upper chambers of the heart. These openings allow the right side of the heart to take over the work of pumping blood to both the lungs and the body^[3].

The critical problem arises shortly after birth. These special connections that helped the baby survive in the womb naturally begin to close within the first few hours to days of life. This is normal for healthy babies, but for babies with HLHS, closing these connections is life-threatening. When the ductus arteriosus closes, oxygen-rich blood cannot reach the body effectively. The baby’s organs, including the brain, kidneys, and liver, do not receive enough oxygen-rich blood.

Without treatment, babies with HLHS develop severe symptoms rapidly. They may show blue or gray coloring of the skin, lips, and nails—a condition called cyanosis—because their blood doesn’t carry enough oxygen. They may have extreme difficulty breathing, rapid heartbeat, weak pulses, cold extremities, and may become very sleepy or unresponsive. As the condition worsens, the baby can go into shock, meaning the body’s organs are failing due to lack of blood flow and oxygen^[1][2].

If left untreated, HLHS is fatal within the first hours to days of life. This is why immediate medical intervention with medicines to keep the ductus arteriosus open, followed by surgery, is absolutely necessary for survival^[5][10].

Possible Complications

Even with appropriate treatment, children with HLHS can experience various complications throughout their lives. Understanding these potential challenges helps families and medical teams watch for early warning signs and respond quickly when problems arise.

One significant concern involves the heart’s ability to keep functioning over time. Heart failure is the most common cause of death and the most common reason these patients eventually need a heart transplant. The right ventricle, which takes over the work of pumping blood to the entire body, is not designed for this heavy workload over many years. Over time, this chamber can become weakened or enlarged, making it less effective at pumping blood^[17].

Abnormal heart rhythms, called arrhythmias, can develop as children with HLHS grow. These irregular heartbeats can range from minor issues that cause no symptoms to serious problems that require medication or other interventions. Some children may need a pacemaker or other device to help regulate their heart rhythm.

Blood clots, or thromboembolic events, represent another serious risk. After the surgeries that create the unique circulation pattern in HLHS patients, blood may not flow as smoothly through the heart and blood vessels. This can lead to clot formation. These clots can travel through the bloodstream and block blood vessels in vital organs like the brain, causing strokes, or in the lungs, causing breathing problems^[6].

A condition called protein-losing enteropathy can occur in some HLHS patients, particularly after the final Fontan surgery. In this complication, the intestines lose protein into the digestive tract instead of absorbing it properly. This leads to swelling throughout the body, poor nutrition, and weakened immunity. Children with this condition may have frequent infections and poor growth^[6].

Liver problems can develop over time. The unique way blood flows after HLHS surgeries can cause increased pressure in the veins returning to the heart. This increased pressure affects the liver, which may become scarred or damaged. Some patients develop liver disease years after their heart surgeries.

Children with HLHS often experience developmental delays that go beyond what might be expected from having a chronic illness. These can include delays in speech, motor skills, learning, and social development. Some children may need special educational support or therapy services. The reasons for these developmental challenges are complex and may relate to reduced oxygen delivery to the brain before and immediately after birth, the effects of heart surgery on a developing brain, or other factors^[8].

Kidney function may decline over time due to periods when the kidneys received inadequate blood flow, medications, or the effects of repeated medical procedures. Regular monitoring of kidney function is important throughout life.

Some children develop problems with the connections or pathways created during surgery. Blood vessels may narrow, or abnormal connections may form that allow blood to flow in unintended directions. These issues may require additional procedures or surgeries to correct.

Impact on Daily Life

Living with HLHS affects not just the child’s physical health but touches every aspect of daily life for the entire family. Understanding these impacts can help families prepare and find ways to adapt.

From a physical perspective, children with HLHS may tire more easily than their peers. Activities that seem simple for other children—running, playing sports, or even walking up stairs—may leave a child with HLHS feeling exhausted. This doesn’t mean children should avoid physical activity altogether. In fact, appropriate exercise is important for overall health. However, families often need to learn how to balance activity with rest and recognize signs that their child needs to slow down.

Many children with HLHS have lower oxygen levels in their blood than children with normal hearts. This can give their skin a slightly blue or grayish tint, particularly around the lips and fingernails. While this is expected with HLHS, sudden changes in color or increased blueness should prompt immediate medical attention.

Feeding challenges are common, especially in babies and young children with HLHS. Eating requires energy, and babies with heart problems often tire before they’ve taken in enough calories. They may sweat excessively during feedings or breathe heavily. Some babies need special high-calorie formulas or feeding tubes to ensure they receive adequate nutrition for growth and development^[2].

Emotionally, both children and parents face unique challenges. Young children may not understand why they can’t keep up with their siblings or friends. As they grow older and become more aware of their condition, they may feel different or isolated from peers. Some children develop anxiety about medical procedures or worry about their health. Parents often experience ongoing anxiety about their child’s future health and survival, even when their child is doing well.

The social impact extends to school and friendships. Children with HLHS may miss school for medical appointments, procedures, or hospitalizations. This can make it harder to keep up academically and maintain friendships. Teachers and school staff need to understand the child’s condition and limitations. Some children may need accommodations like extra time for assignments, permission to rest when tired, or restrictions on physical education activities.

Family dynamics shift when a child has HLHS. Siblings may feel neglected when parents’ attention focuses intensely on the child with heart disease. They may feel scared about their brother or sister’s health or resentful about how the condition affects family plans and activities. Financial stress is common, as families navigate medical bills, time away from work for appointments and hospitalizations, and sometimes the need for one parent to reduce work hours or stop working to manage the child’s care.

Travel requires extra planning. Families need to ensure they’re near appropriate medical facilities if their child has problems. Air travel may require clearance from the child’s cardiologist due to changes in oxygen levels at high altitudes. Keeping up with multiple medications, understanding dosing schedules, and never running out of necessary medicines becomes part of daily life.

Despite these challenges, many families find ways to create a fulfilling life. Connecting with other families who understand the journey can provide tremendous support. Many hospitals have support groups or can connect families with others who have children with HLHS. Learning about the condition, becoming active participants in care decisions, and maintaining open communication with the medical team helps families feel more in control.

Some practical strategies families find helpful include maintaining routines as much as possible to provide stability, celebrating small victories and milestones, allowing the child to participate in decisions about their care when age-appropriate, encouraging the child to pursue interests and hobbies they enjoy and can safely participate in, and ensuring that all family members, including siblings, receive attention and support.

Support for Family: Understanding Clinical Trials

Clinical trials represent an important avenue for advancing treatment and improving outcomes for children with HLHS. However, many families feel uncertain about what clinical trials are, whether participating is safe, and how to find appropriate studies for their child.

A clinical trial is a research study that tests new treatments, procedures, or ways of managing a condition. For HLHS, clinical trials might test new surgical techniques, medications to improve heart function, ways to prevent complications, or strategies to improve developmental outcomes. Every treatment we use today for HLHS was once tested in clinical trials, which is how we know these approaches are safe and effective.

Participating in a clinical trial is always voluntary. No family should ever feel pressured to enroll their child. Before joining any trial, the research team provides detailed information about what the study involves, potential risks and benefits, and alternatives. This process, called informed consent, ensures families have all the information they need to make an educated decision.

Clinical trials have strict rules to protect participants. An independent group called an Institutional Review Board reviews every study to ensure it’s ethical and that risks are reasonable compared to potential benefits. During the trial, researchers monitor participants carefully and will stop the trial if safety concerns arise.

There are potential benefits to participating in clinical trials. Children in trials may gain access to new treatments before they’re widely available. They receive extremely careful monitoring and attention from the medical team. Families often report feeling they’re contributing to knowledge that could help other children with HLHS in the future, which gives meaning to their child’s struggles.

However, there are also considerations to keep in mind. Some trials involve placebos, meaning some participants receive the standard treatment rather than the new treatment being tested. This is sometimes necessary to determine if a new treatment truly works better. Trials may require extra visits, tests, or procedures beyond routine care. The new treatment being tested might not work or might have unexpected side effects.

Families can find clinical trials in several ways. The child’s cardiologist or cardiac surgeon is usually the best first resource, as they often know about relevant trials at their institution or other centers. The U.S. government maintains a database of clinical trials at ClinicalTrials.gov where families can search for studies enrolling patients with HLHS. Major children’s hospitals with cardiac programs often have research coordinators who can provide information about available studies.

When considering a clinical trial, families should ask questions. What is the purpose of the study? What treatments or procedures are involved? How does this differ from standard care? What are the possible risks and benefits? How long will participation last? Will there be extra costs? Can we stop participating if we change our minds? Understanding these details helps families make informed decisions that feel right for their situation.

Family members can support the patient in preparing for trial participation by learning as much as possible about the study, asking the medical team to explain anything unclear, discussing the decision with the child in age-appropriate ways, keeping detailed records of appointments and procedures, maintaining open communication with the research team, and being prepared for the possibility that the trial might not work out as hoped.

Not every child with HLHS will be eligible for every trial. Studies have specific criteria about who can participate, based on factors like age, previous surgeries, current health status, or other conditions. If a child doesn’t qualify for one trial, they might qualify for another in the future. The most important thing is maintaining a strong relationship with the medical team, who can guide families toward appropriate opportunities when they arise.